rare-diseases-2016_scientifictracks-workshop

8 / 30

Page 31
Notes:
conferenceseries.com
October 26-27, 2016 Chicago, USA
Annual Congress on
Rare Diseases & Orphan Drugs
Volume 7, Issue 5 (Suppl) J Genet Syndr Gene Ther
ISSN: 2157-7412 JGSGT, an open access journal Rare Diseases 2016
October 26-27, 2016
Engaging families in research to drive progress: Phelan-McDermid Syndrome International Registry
(PMSIR) and the Phelan-McDermid Foundation Data Network (PMS_DN)
Megan O’Boyle
Phelan-McDermid Syndrome Foundation, USA
Phelan-McDermid Syndrome (PMS) is a rare genetic condition associated with autism spectrum disorder, seizure disorders
and severe to profound intellectual disability. Today, there is no cure for PMS and patient interaction with health care and
research is for the most part navigated by parents and caregivers. In 2011, the PMS Foundation launched the PMS International
Registry (PMSIR), centralizing data about the PMS community and removing barriers for researchers studying the condition and
its associated interventions. The PMSIR has been family-led since its inception. In 2013, the Foundation was awarded a PCORI
contract to participate in PCORnet as a Patient Powered Research Network and establish the PMS Data Network (PMS_DN),
integrating patient-reported outcomes from the PMSIR with concepts extracted from electronic health records of PMS patients. The
PMS_DN, a collaboration between the PMS Foundation, Harvard Medical School Center for Biomedical Informatics and Boston
Children’s Hospital, advances knowledge, care and treatment of PMS and related conditions by integrating diverse, complex data
sources into a richly populated, high quality and centralized database to facilitate patient-centered research. The PMS_DN technical
infrastructure is an i2b2/tranSMART data warehouse and web interface, which integrates patient reported outcomes (PROs), curated
genetic testing results and knowledge extracted from clinical notes. The PMS_DN excels in engaging families in data sharing activities
and prioritizing research questions, facilitating family communication and promoting transparency of patient data use in research,
through the leadership of exceptional parents and the authentic engagement of patients and caregivers as champions for their families.
Biography
Megan O’Boyle is the Principal Investigator for the Phelan-McDermid Syndrome Data Network (PMS_DN, PCORnet) and the Phelan-McDermid Syndrome
International Registry (PMSIR). She is passionate about the value of the patient’s voice in research, drug development, clinical trial design, development of related
legislation and quality of life decisions. She advocates for data sharing, collaborating with other advocacy groups, sharing resources and streamlining IRB practices
and policies.
Megan O’Boyle, J Genet Syndr Gene Ther 2016, 7:5 (Suppl)